Oncologists scout new directions for KS and lymphoma therapies.
Mascolini
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000628:therapy*; D008935:Mitoguazone / Q000009:adverse effects / Q000627:therapeutic use; D017239:Paclitaxel / Q000627:therapeutic use; D010166:Palliative Care; D010778:Photochemotherapy; D012008:Recurrence; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D002583:Uterine Cervical Neoplasms / Q000150:complications
D000998:Antiviral Agents; D006063:Chorionic Gonadotropin; D015474:Isotretinoin; D008935:Mitoguazone; D017239:Paclitaxel